The 2003 severe acute respiratory syndrome (SARS) epidemic in China has lessons to teach hospitals on how to prevent the spread of other respiratory diseases, according to new research appearing in the April 15 issue of Clinical Infectious Diseases, currently available online.
Hospitals were epicenters of SARS transmission in Guangzhou province and Hong Kong in 2003. In hospitals with especially severe outbreaks, the researchers looked at environmental and administrative factors that may have assisted in the transmission of the infection from one patient to another. This new study suggests that hospital beds placed too closely together, hospital staff working while having symptoms of SARS, and the use of oxygen therapy were the most significant risk factors associated with the spread of SARS in 26 hospitals in Guangzhou and Hong Kong.
These findings have implications for controlling other respiratory disease threats, including pandemic influenza, according to senior author Joseph Sung, MD, PhD, of the Chinese University of Hong Kong. "The lesson we learned during the SARS epidemic," he said, "was that the hospital can be a breeding ground for infectious disease. Nosocomial infection can amplify an infectious disease outbreak. It is very important to provide adequate space in hospital wards and implement effective infection control measures in order to avoid cross-contamination in hospitals."
Unfortunately, the authors note, it is a common practice for hospitals to increase the number of hospital beds inside a ward to meet the increasing demand, especially during an epidemic. When the distance between beds is reduced, exhaled droplets can spread from one patient to adjacent patients, spreading infection.
Healthcare staff working while sick are an obvious source of infection. This study found that hospitals could reduce the risk of outbreaks by providing staff with handwashing, showering, and changing facilities.
The use of oxygen therapy, including both the use of high flow rate oxygen masks and bi-level positive airway pressure ventilation, increased the risk of the spread of SARS. The authors hypothesize that these treatments may propel infectious air from these patients farther than without masks or ventilation. Alternatively, they may generate more infectious aerosols.
"There is a gap in the knowledge of how oxygen and ventilation therapy may promote the spread of infection. Future research should include investigating the safety of high flow rate oxygen therapy and positive pressure ventilation in medical facilities and effective ways of ventilating hospitals and clinics to avoid spreading of droplets," said Sung. "These findings are relevant not only for SARS," he concluded, "but also for other infections transmitted by droplets such as influenza."
Source: Infectious Diseases Society of America (IDSA)
Ensuring Safety and Comfort: The Urgent Need for Well-Fitted PPE in Health Care
April 5th 2024Personal protective equipment (PPE) stands as the first line of defense against infectious diseases in health care. Yet, the issue of ill-fitting PPE, especially for women, remains a significant challenge.
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.